National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non–high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.This is the publisher’s final pdf. The article is copyrighted by National Lipid Association and published by Elsevier. It can be found at: http://www.journals.elsevier.com/journal-of-clinical-lipidology/Keywords: Clinical recommendations, Residual risk, Elderly, Team-based care, Dyslipidemia, Human immunodeficiency virus, Lifestyle therapies, Adherence, Children, Rheumatoid arthriti

Effects of an eight-week progressive distance running program on isolated electrocardiographic and vectorcardiographic parameters in untrained college males

This study was designed to determine specific electrocardiographic and vectorcardiographic effects of an eight-week progressive distance running program in untrained college males. Specific objectives were to measure changes in (1) resting heart rate, (2) Q-T interval, QRS duration, and QRS and T wave height in lead II and V4 of the electrocardiogram, (3) maximum QRS and T vector axis in three planes of the vectorcardiogram, (4) QRS-T angle and maximum QRS and T vector magnitude in the frontal plane of the vectorcardiogram, and (5) Balke treadmill test exercise tolerance

In search of self-awareness: Results of the National Lipid Association 2010 Lipid Pulse Membership Survey

In 2010 a survey of the National Lipid Association (NLA) membership was developed and launched with the objective of exploring the demographics, practice patterns, and educational needs of the health professionals in our organization involved in the practice of clinical lipidology. To report the results of this survey and use this information to enable the organization to better serve the needs of our membership. A 30-question survey was administered to the NLA membership before and shortly after the Annual Scientific Sessions in May, 2010. Demographic information, test ordering patterns, educational needs and resources, and technology awareness of 640 valid respondents was assessed. The respondents represent a balanced mix of practitioners in rural and metropolitan population centers throughout the United States. Physicians represent 67%, nurse practitioners and physician assistants 16%, and pharmacists 8% of the respondents. Among physicians, 50% are internal medicine or family medicine specialists, 32% cardiologists, and 11% endocrinologists. Most working in lipid clinics reported that their clinic was financially solvent. The respondents believed that adjunctive lipoprotein testing was clinically useful in risk prediction. The greatest educational needs included statin intolerance; strategies for improving compliance; metabolic syndrome; and lipoprotein particle and apolipoprotein B concentration. The most important sources of lipid information were the Journal of Clinical Lipidology and the NLA Annual Scientific Sessions. The survey provided valuable information that may be used to better serve the practice and educational needs of the membership of the NLA

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non–high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care

JacobsonNationalLipidAssociation.pdf

An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non–high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.Keywords: Human immunodeficiency virus, Dyslipidemia, Rheumatoid arthritis, Residual risk, Children, Lifestyle therapies, Clinical recommendations, Team-based care, Elderly, Adherenc

JacobsonNationalLipidAssociationErratum.pdf

An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non–high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.Keywords: Team-based care, Residual risk, Dyslipidemia, Human immunodeficiency virus, Lifestyle therapies, Clinical recommendations, Children, Elderly, Adherence, Rheumatoid arthritisKeywords: Team-based care, Residual risk, Dyslipidemia, Human immunodeficiency virus, Lifestyle therapies, Clinical recommendations, Children, Elderly, Adherence, Rheumatoid arthriti